Search Results

You are looking at 1 - 10 of 10 items for :

  • Framingham Risk Score x
Clear All
Open access

Vaia D. Raikou

coronary heart disease is the Framingham risk score (FRS). According to the National Institutes of Health, the patients having chronic kidney disease are considered as having a coronary heart disease risk equivalent, meaning that they are primarily patients with a 10-year risk for myocardial infarction or coronary death >20%, despite without known coronary heart disease. [ 8 ] Metabolic acidosis, a common condition and an important manifestation of the late stage of chronic kidney disease, leads to clinically significant consequences, including bone disease disorders

Open access

Manta Andrei, Maștaleru Alexandra, Oancea Andra, Anghel Razvan Constantin, Roca Mihai, Leon-Constantin Maria Magdalena and Mitu Florin

the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1-12. 4. Wang H, Sun Y, Yi X, Zhang L. Evaluation of the Framingham risk score and pooled cohort risk equation for prediction of cardiovascular risk in low resource areas: Insights from Asian rural population. Int J Cardiol. 2018;265:237. 5. Fonseca FAH, Izar MCO. Prevalence of Metabolic Syndrome and Framingham Risk Score in Vegetarian and Omnivorous Apparently Healthy Men. Arq Bras Cardiol. 2018;110(5):438-439. 6. Vanavanan S, Srisawasdi P, Rochanawutanon M, Kumproa N

Open access

Primary prevention strategy for cardiovascular disease in Lithuania

(“A Funding Programme for the Screening and Preventive Management of the High Cardiovascular Risk Individuals” – main results: 2006–2017 years)

Aleksandras Laucevičius, Egidija Rinkūnienė, Ligita Ryliškytė, Vytautas Kasiulevičius, Dalius Jatužis, Žaneta Petrulionienė, Jolita Badarienė, Rokas Navickas, Agnė Jucevičienė, Sandra Kutkienė, Svetlana Solovjova, Viktorija Andrejevaitė, Ingrida Lisauskienė, Jūratė Zupkauskienė, Roma Puronaite, Romualdas Gurevičius and Jurgita Mikolaitytė

, Stijnen T, Bucher HC, Hunink MG, et al. Validity of the Framingham point scores in the elderly: results from the Rotterdam study. Am Heart J 2007;154(1):87–93. [37] Reissigova J, Zvarova J. The Framingham risk function underestimated absolute coronary heart disease risk in Czech men. Methods Inf Med 2007;46(1):43–9. [38] Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The Metabolic Syndrome and Cardiovascular Risk. A Systematic Review and Meta-Analysis. Am Coll Cardiol 2010;56(14):1113–32. [39] Leal J, Luengo-Fernández R, Gray A

Open access

Jolita Badarienė, Jelena Čelutkienė, Dovilė Petrikonytė, Jūratė Balsytė, Egidija Rinkūnienė, Ligita Ryliškytė, Vilma Dženkevičiūtė, Alma Čypienė, Romualdas Kizlaitis, Roma Puronaitė and Aleksandras Laucevičius

References [1] Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol 2010;35:72–115. [2] WHO, The top 10 causes of death. WHO n.d. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/index2.html [accessed March 20, 2015]. [3] Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005

Open access

Oleg Sychov, Artem Borodai, Svetlana Fedkiv, Elina Borodai, Taisia Getman and Andrei Rybak

;272(1-2):36-42. [25] Kobayashi A, Iguchi M, Shimizu S, Uchiyama S. Silent cerebral infarcts and cerebral white matter lesions in patients with nonvalvular atrial fibrillation. J Stroke Cerebrovasc Dis 2012;21(4):310-7. [26] Jeerakathil T, Wolf P, Beiser A, Massaro J, Seshadri S, D’Agostino R, DeCarli C. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 2004;35(8):1857-61. [27] Pisters R, Olesen J, Lip G. The role of echocardiography in stroke risk assessment in patients with atrial fibrillation: is it

Open access

Nikolaos-Dimitrios Pantzaris, Christina Platanaki, Charalampos Pierrako, Vasilios Karamouzos and Dimitrios Velissaris

O, Zararsiz G, Hamit Kücük H, Gürsoy S, et al . Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis. J Clin Lab Anal 2013; 27: 72–6. 10.1002/jcla.21564 Celikbilek M Dogan S Ozbakir O Zararsiz G Hamit Kücük H Gürsoy S Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis J Clin Lab Anal 2013 27 72 6 9 Shah N, Parikh V, Patel N, Patel N, Badheka A, Deshmukh A, et al . Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality

Open access

Alireza Sepehri Shamloo, Nikolaos Dagres, Arash Arya and Gerhard Hindricks

. Arrhythmia & electrophysiology review. 2018; 7 (2):118-27. doi:10.15420/aer.2018.18.2. 35. SCHNABEL RB, YIN X, GONA P, LARSON MG, BEISER AS, MCMANUS DD et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study . Lancet (London, England). 2015; 386 (9989):154-62. doi:10.1016/s0140-6736(14)61774-8. 36. DE BECKER B, DE BORNE PHILIPPE V. Treatment of hypertension to prevent atrial fibrillation. Current pharmaceutical design. 2018. doi:10.2174/1381612825666181127100437. 37

Open access

Theodora Benedek, Nora Rat, Roxana Hodas, Diana Opincariu, András Mester and Imre Benedek

greater coronary artery calcification progression in subjects at intermediate risk by coronary calcium score: a serial study using non-contrast cardiac CT. Atherosclerosis. 2011;218:363-368. doi: 10.1016/j. atherosclerosis.2011.07.093. 14. Bettencourt N, Toschke A, Leite D, et al. Epicardial adipose tissue is an independent predictor of coronary atherosclerotic burden. International Journal of Cardiology. 2012;158:26-32. doi: 10.1016/j.ijcard.2010.12.085. 15. Mahabadi A, Berg M, Lehmann N, et al. Association of Epicardial Fat With

Open access

Amir Hodzic, Virginie Ribault, Pascale Maragnes, Paul Milliez, Eric Saloux and Fabien Labombarda

;378:140–6. 10.1016/S0140-6736(11)60471-6 Lind M Bounias I Olsson M Gudbjörnsdottir S Svensson AM Rosengren A Control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study Lancet 2011 378 140 6 4 Kannel WB, Mc Gee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979;2:120–6. 10.2337/diacare.2.2.120 Kannel WB Mc Gee DL Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study Diabetes Care 1979 2 120 6 5 Fang ZY, Prins JB

Open access

Theodora Benedek, István Kovács and Imre Benedek

.01.083. 16. Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb Haemost. 2010;103:696-709. doi: 10.1160/TH09-10-0688. 17. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925-1934. doi: 10.1016/S0140-6736(05)67704-5. 18. Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events